|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/616 | (2006.01) |
| A61K 31/616 | (2013.01) | ||
| A61K 9/0075 | (2013.01) | ||
| A61K 31/4365 | (2013.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 3107548 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15752250.9 |
| Europos patento paraiškos padavimo data | 2015-02-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-06-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/016969 |
| Data | 2015-02-20 |
| (87) | Numeris | WO 2015/127315 |
| Data | 2015-08-27 |
| (30) | Numeris | Data | Šalis |
| 201461942545 P | 2014-02-20 | US | |
| 201462031811 P | 2014-07-31 | US |
| (72) |
YADIDI, Kambiz , US
|
| (73) |
Otitopic Inc. ,
120 Park Avenue, New York, NY 10017,
US
|
| (54) | DRY POWDER FORMULATIONS FOR INHALATION |
| DRY POWDER FORMULATIONS FOR INHALATION |